Abstract:OBJECTIVE:To investigate the pathogenesis of thromboembolism in patients with mitral stenosis in a pre-thrombotic state. METHODS:The biochemical markers' levels in plasma for platelet activity [soluble P-selectin (GMP-140)], states of thrombin generation [antithrombin III (AT III) and protein C (PC)], fibrinolysis [D-dimer (DD), plasminogen activator inhibitor 1 (PAI-1), tissue plasminogen activator (t-PA) and FDP] and von Willebrand factor (vWF) were determined from blood specimens obtained from the femoral veins and arteries and the right and left atria of 43 consecutive patients (20 with atrial fibrillation and 23 with sinus rhythm) with mitral stenosis (MS), undergoing percutaneous mitral valvuloplasty. The same parameters were compared with those of 15 control subjects, who had no detectable heart disease, but with paroxysmal supraventricular tachycardia undergoing radiofrequency catheter ablation of the left accessory pathway through a transseptal passage. RESULTS:Blood from the left atrium contained an excessive amount of platelet activity, thrombin generation and fibrinolysis compared with the blood from the right atrium, and the femoral veins and arteries. However blood from the right atrium was much lower in these activities when compared with those from the left atrium, and the femoral veins and arteries in both groups. Compared with those in the control subjects, GMP-140 in the left atrium was significantly higher (P < 0.05) and AT III was significantly lower (P < 0.05) in patients with MS. Compared with the patients with MS and spontaneous left atrial echocontrast (LASEC) = 1, the patients with MS and LASEC >/= 2 had significantly higher levels of GMP-140 in plasma (P < 0.05), and significantly lower levels of AT III (P < 0.05) and PC (P < 0.01) levels in the left atrium. However, there were no significant differences between patients with atrial fibrillation and those with sinus rhythm regarding amounts of plasma coagulation markers in the left atrium. Univariate regression analysis revealed that LASEC was negatively correlated with plasma levels of blood from the left atria in the patients with MS. CONCLUSION:Coagulability is increased in the left atria of patients with MS and is positively correlated with LASEC.

JPH2 Gene Expression in Persistent Atrial Fibrillation with Mitral Valve Disease

Expression of BRD4 in patients with nonvalvular atrial fibrillation and its role in postoperative recurrence and the development of atrial fibrosis

[Expression of Connexin in Atrium of Patients with Atrial Fibrillation and Its Signal Transduction Pathway].

Gap junction and Na+-H+ exchanger alternations in fibrillating and failing atrium.

Activation of Extracellular-Signal Regulated Kinase and Protein Phosphatases in Human Atria During Atrial Fibrillation

E0356 the Research on Calcium Homeostasis Expression and Gene Transcription of Atrial Myocytes in Patients with Atrial Fibrillation

Changes of Protein Expression of Connexin 40, 43 in Human Atrial Fibrillation

JP-2 Gene Expression Affects Excitation-Contraction Coupling in the Dilated Cardiomyopathy Heart Failure

Hypercoagulability Existing in the Local Left Atrium of Patient with Mitral Stenosis

Changes of the mRNA and Protein Expression of T-type Calcium Channels in PVA of Human with Chronic Atrial Fibrillation

Functional genomic study on atrial fibrillation using cDNA microarray and two-dimensional protein electrophoresis techniques and identification of the myosin regulatory light chain isoform reprogramming in atrial fibrillation

Identification of atrial fibrillation-associated lncRNAs in atria from patients with rheumatic mitral valve disease.

Change of gene expression of hepatocyte growth factor, connective tissue growth factor and trails forming growth factor-beta 1 in human atrium during atrial fibrillation

Involvement of Apelin/APJ Axis in Thrombogenesis in Valve Heart Disease Patients with Atrial Fibrillation.

Does the expression of transforming growth factor β-1: affect the outcome of the radiofrequency modified maze procedure in patients with rheumatic atrial fibrillation?

Identification of Atrial Fibrillation-Associated Micrornas in Left and Right Atria of Rheumatic Mitral Valve Disease Patients.

Quantitative proteomics of changes in energy metabolism-related proteins in atrial tissue from valvular disease patients with permanent atrial fibrillation.

Study of chloride channel ClC-3 gene expression in patient with atrial fibrillation

Abstract 15023: Junctophilin-2 (JPH2) Interactome in Ventricular Myocytes is Subcellular Compartment-dependent and Subject to Remodeling During Hypertrophy Leading to Heart Failure

Molecular Signatures of Human Chronic Atrial Fibrillation in Primary Mitral Regurgitation

[Changes of Interleukin-1Beta and Tumor Necrosis Factor-Alpha of Right Atrial Appendages in Patients with Rheumatic Valvular Disease Complicated with Chronic Atrial Fibrillation].